NOV 01, 2017 9:00 AM PDT

WEBINAR: Clinical Applications and Strategies Using Procalcitonin (PCT) to Improve Patient Outcomes

Sponsored by: Abbott Molecular
Speakers
  • Director of Critical Services Swedish Covenant Hospital
    Biography
      Eric Howard Gluck, M.D. received his medical degree in medicine from New York Medical College in Valhalla, New York. He completed his residency at Beth Israel Medical Center in New York City and a pulmonary fellowship at the University of Utah School of Medicine in Salt Lake City, Utah. He currently serves as the director of Critical Care Services and Chief Academic Officer at Swedish Covenant Hospital in Chicago, Illinois. In addition, Dr. Gluck is a Professor of Medicine at the Finch University of Health Sciences/The Chicago Medical School. Dr. Gluck is part of many professional societies. Most notably, he is a fellow of the Society of Critical Care Medicine, the American College of Chest Physicians, and the Chicago Institute of Medicine. He is a member of the American Thoracic Society, the Society of Sigma Xi, Alpha Omega Alpha, and the American Society of Law, Medicine, and Ethics. He has presented lectures and authored many peer reviewed articles and chapters in the field of pulmonary critical care and has been in practice for more than 20 years. More recently, Dr. Gluck has been leader at developing and implementation strategies at his institution to reduce the risk of sepsis in critically ill patients.

    Abstract:

    DATE:  November 1, 2017

    TIME:  9:00am PT, 12:00pm ET

    Over 1.6 million people are diagnosed with sepsis in the U.S. each year1 and sepsis is the #1 cost of hospitalization (over $24 billion each year)1. Having a biomarker that can quickly identify sepsis is critical because mortality increases 8% every hour that treatment is delayed1.

    Procalcitonin (PCT) helps determine if the patient has a bacterial infection (sepsis), the severity of the infection and is the patient responding to therapy2. PCT is a more accurate diagnostic parameter for sepsis and a better predictor of mortality and a more reliable marker than other biomarkers3. PCT also provides clinicians a mechanism for antibiotic stewardship2.

    1. Sepsis Alliance Website: http://www.sepsis.org/downloads/2017_sepsis_facts_media.pdf3
    2. Thermo Scientific B-R-A-H-M-S PCT Improving infection management.
    3. Shiferaw, et al. The Role of Procalcitonin as a Biomarker in Sepsis. J Infect Dis Epidemiology. 2016;2:006 Vol 2.

    Expected Outcomes:

    • Understand the clinical utility of PCT.
    • Incorporate  PCT protocols as part of sepsis management.
    • Demonstrate the impact PCT can have on clinical and financial outcomes

     


    Show Resources
    You May Also Like
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    Loading Comments...
    Show Resources